Mini Review
Published on 13 May 2025
Not just for mature audiences: myeloproliferative neoplasms in children, adolescents, and young adults
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1483322
- 1,987 views
Type at least 3 characters
177 articles
articles
Mini Review
Published on 13 May 2025
Erythroblast island macrophages and their surface markers
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1580621
- 2,487 views
Original Research
Published on 06 May 2025
Disease and treatment burden in patients with leukaemia: family members/partner perspective
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1570055
- 2,938 views
- 1 citation
Case Report
Published on 24 Apr 2025
Case Report: Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2025.1547209
- 2,757 views
Clinical Trial
Published on 22 Apr 2025
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1554764
- 2,025 views
Review
Published on 14 Apr 2025
Metabolic reprogramming of fetal hematopoietic stem and progenitor cells by maternal obesity
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2025.1575143
- 3,140 views
- 1 citation
Original Research
Published on 09 Apr 2025
Anemia and its predictors among neonates at Wachemo University teaching hospital, Central Ethiopia: a facility-based cross-sectional study
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1550664
- 2,348 views
- 1 citation
Brief Research Report
Published on 03 Apr 2025
Assessing maternal and perinatal complication incidence in pregnant patients with sickle cell disease: a retrospective analysis of transfusion therapy at a tertiary care hospital
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1549241
- 1,437 views
- 1 citation
Original Research
Published on 21 Mar 2025
Cochrane’s contribution to global health: three decades of progress in sickle cell disease research
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1535100
- 2,050 views
- 1 citation
Review
Published on 21 Mar 2025
Exercise and diet studies among patients living with multiple myeloma: current evidence and considerations of patient preferences
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1550681
- 4,045 views
Original Research
Published on 17 Mar 2025
HPLC first approach in detecting thalassemia and other common hemoglobinopathies is more cost and time effective
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1461498
- 5,683 views
- 2 citations
Case Report
Published on 04 Mar 2025
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1552200
- 1,931 views
Editorial
Published on 04 Mar 2025
Editorial: Hematopoietic stress in stem cell homeostasis and disease pathogenesis
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2025.1571674
- 1,364 views
Review
Published on 03 Mar 2025
Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1435193
- 2,825 views
- 1 citation
Original Research
Published on 27 Feb 2025
FACIT-Fatigue scale in patients with cold agglutinin disease: psychometric validation and estimation of clinically meaningful change
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1490130
- 2,675 views
- 2 citations
Case Report
Published on 26 Feb 2025
Acquired von Willebrand disease associated with smoldering multiple myeloma and hereditary hemorrhagic telangiectasia successfully treated with daratumumab, pomalidomide, and dexamethasone: hitting three birds with one stone? – case report
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1499500
- 2,107 views
Mini Review
Published on 26 Feb 2025
The role of glucocorticoids in erythropoiesis
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1540152
- 4,515 views
- 4 citations
Original Research
Published on 21 Feb 2025
Time to initiation of antiresorptive agents in multiple myeloma to reduce skeletal related events
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1521017
- 1,428 views
Mini Review
Published on 07 Feb 2025
The aging hematopoietic stem cell niche: a mini review
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2025.1525132
- 6,239 views
- 2 citations
Editorial
Published on 24 Jan 2025
Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2025.1548984
- 2,088 views
Original Research
Published on 21 Jan 2025
Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1502166
- 4,629 views
- 2 citations
Case Report
Published on 16 Jan 2025
Case report: VEXAS syndrome: first documented cases in Latin America
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1501337
- 1,744 views
Case Report
Published on 10 Jan 2025
Case report: A decade-long journey with cyclic thrombocytopenia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2024.1482891
- 2,070 views
Original Research
Published on 26 Dec 2024
Unique target binding by the C-terminal region of FHR1 provides a new perception of aHUS pathology
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2024.1469176
- 1,929 views
- 2 citations